RDD Blog » drug discovery

R&D Directions Insider

Archive for the ‘ drug discovery ’ Category

‘Breakthrough’ startups reap investments from new early-stage fund

Wednesday, January 25th, 2012

Cambridge, Mass.-based Flagship Ventures recently launched the company's largest fund to date, raising $270 million for its life sciences funds, money that will add around 20 new biotechnology companies to Flagship's portfolio, according to officials. With the closing of the new fund, the company now has ...

Posted in Uncategorized, drug discovery | No Comments »

Survey: Lack of funds, regulatory climate threaten biomedical industry

Friday, January 13th, 2012

Future growth for the biomedical industry faces growing and unprecedented threats, according to a newly released survey of CEOs from life sciences companies in California, the largest biomedical cluster in the world. The three biggest threats reported were access to capital, a burdensome and uncertain regulatory environment, and lack of ...

Posted in FDA, Uncategorized, clinical trials, drug discovery | No Comments »

Biotech startup continues hot streak

Tuesday, January 10th, 2012

If you have been following some of the buzz out of the JP Morgan Healthcare Conference this week, access to traditionalÂ venture capital remains difficult for biomedical companies, particularly for biotech startups. Thus, opportunities to forge licensing agreements or corporate partnerships with large biopharma companies has become increasingly vital for startups ...

Posted in Uncategorized, drug discovery | No Comments »

Smart pill quickens drug assessment process

Friday, October 28th, 2011

In case you missed the news, there was a pretty neat technology unveiling at this week's annual meeting of the American Association of Pharmaceutical Scientists, which wrapped up yesterday. New partnersÂ Bio-Images Research Ltd. and Medimetrics Personalized Drug Delivery B.V. introduced a smart pill technology called the IntelliCap, declaring it a ...

Posted in Uncategorized, clinical trials, drug discovery | No Comments »

Molecular targeted therapy progress with lung cancer

Tuesday, July 5th, 2011

(This is a guest post from Sally Church, Ph.D, who writes the Pharma Strategy Blog. If you are on Twitter, follow her here.) In this second part of the ASCO report, we look at another area where significant strides are being made with molecular targeted therapy, lung cancer. For years, this ...

Posted in cancer, clinical trials, drug discovery | 1 Comment »

Quintiles backs innovative breast cancer trial

Thursday, April 14th, 2011

Today, Quintiles got into the "spy" game - the I-SPY 2 clinical trial, to be exact. The contract research organization has committed a total of $2.6 million over four years to support the trial, formally known as the "Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular ...

Posted in CRO, FDA, clinical trials, drug discovery | No Comments »

Benlysta nod should benefit remaining lupus prospects

Thursday, March 10th, 2011

FDA'sÂ approval of Benlysta is indeed an historic moment for lupus patients, a community that has waited 50 years for a new treatment. The milestone, however, may have even bigger ramifications going forward. The door for additional â€“ and perhaps more effective â€“ new drugs for the autoimmune disorder has suddenly ...

Posted in antibodies, clinical trials, drug discovery | No Comments »

Roche appoints head of discovery

Tuesday, February 22nd, 2011

Roche named Anirvan Ghosh, Ph.D., head of discovery for the companyâ€™s central nervous system and translational area, where he will oversee discovery research in the central nervous system discovery and translational area with an emphasis on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression, and neurodevelopment disorders. Using a combination of cellular, ...

Posted in People on the move, drug discovery | No Comments »

J&J’s new lean, green lab to be key R&D hub

Tuesday, February 8th, 2011

In a rare day that didn't include yet another punch from Old Man Winter, Johnson & Johnson executives Friday unveiled ambitious plans for the company's two-year-old Spring House, Pa., research lab, providing media members with their first formal tour of the facility, one leaders expect to become a major J&J ...

Posted in drug discovery | No Comments »

Co-development guidance sets road map, but hurdles remain

Tuesday, January 18th, 2011

You have about a month left to weigh in publicly, if so moved, on FDAâ€™s new draft guidance on the co-development of drugs designed for use in combination therapy. Deadline for written comments is Valentineâ€™s Day. The agency, in its guidelines released before the holidays, acknowledged the need for a ...

Posted in FDA, cancer, clinical trials, drug discovery | No Comments »

©2012 UBM Canon